PREGABALIN 150 MG CAPSULE

PREGABALIN
$0.0550per EA
DEA Schedule CV

Strength

150 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097095805

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

5/22/2024

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211384

On Market Since

7/19/2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-25.6%

5Y

-54.9%

All

-70.9%

Related Drugs

Same classification

No related drugs found.